References
- Ford G, Compton M, Millett G, et al. The Role of Digital Disruption in Healthcare Service Innovation . In: Pfannstiel MA, Rasche C, editors. Service Business Model Innovation in Healthcare and Hospital Management. Springer; 2017. p. 57–70.
- Schallmo A, Daniel R. Digital transformation now! guiding the successful digitalization of yourbusiness. Model: Springer; 2018.
- Shah SS, Gvozdanovic A. Digital health; what do we mean by clinical validation? Expert Rev Med Devices. 2021 Dec;18(sup1):5–8. Epub 2021 Dec 12.
- Manogaran G, Lopez D, Thota C, et al. Big Data Analytics in Healthcare Internet of Things. In: Qudrat-Ullah H, Tsasis P, editors . Innovative Healthcare Systems for the 21st Century. Springer; 2017. p. 263–284.
- Haggerty E. Healthcare and digital transformation. Network Secur. 2017;2017(8):7–11.
- Belliger A, Krieger DJ. The digital transformation of healthcare In: North K, Maier R, Haas O, editors. Knowledge management in digital. Change: Springer; 2018. p. 311–326.
- Cohen D, Hung A, Weinberg E, et al. Healthtech in the fast lane: what is fueling investor excitement. Retrieved from McKinsey & Company: https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/healthtech-in-the-fast-lane-what-is-fueling-investor-excitement. 2020.
- Wang L, Wang H, Xia C, et al. Toward standardized premarket evaluation of computer aided diagnosis/detection products: insights from FDA-approved products. Expert Rev Med Devices. 2020 Sep;17(9):899–918. Epub 2020 Sep 11.
- Boucher EM, Harake NR, Ward HE, et al. Artificially intelligent chatbots in digital mental health interventions: a review. Expert Rev Med Devices. 2021 Dec;18(sup1):37–49. Epub 2021 Dec 31.
- Hong JS, Wasden C, Han DH. Introduction of digital therapeutics. Comput Methods Programs Biomed. 2021 Sep;209:106319. Epub 2021 Jul 29.
- Digital Therapeutics KISTEP; 2020 [cited 2022 Feb 22]. Available from: https://www.kistep.re.kr/board.es?mid=a10306010000&bid=0031&list_no=34994&act=view
- Analysis of the status and development direction of digital therapeutics. ETRI; 2020 [cited 2022 Feb 22]. Available from 2022 Feb 22: https://ksp.etri.re.kr/ksp/plan-report/read.htm?id=790&dataDivCd=01
- Digital Health Trends 2021; IQVIA. 2021 cited 2022 Feb 22. Available from 2022 Feb 22: https://www.iqvia.com/insights/the-iqvia-institute/reports/digital-health-trends-2021
- Ellis TD, Earhart GM. Digital therapeutics in parkinson’s disease: practical applications and future potential. J Parkinsons Dis. 2021;11(s1):S95–S101.
- Park HB, Jang SA. policy proposals for usefulness and publicity of medical artificial intelligence. The Korea Assoc for Public Manage. 2021;35(3):195–217.
- Muensterman ET, Luo Y, Parker JMBT. Prime and sakigake: a comparison between neuroscience and oncology in obtaining preferred regulatory status. Ther Innov Regul Sci. 2020 May;54(3):658–666. Epub 2020 Jan 6.
- Frequently Asked Questions: Breakthrough Therapies [Internet]. US Food and Drug Administration. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/regulatory-information/food-and-drug-administration-safety-and-innovation-act-fdasia/frequently-asked-questions-breakthrough-therapies
- Sakigake Designation [Internet]. Japan Ministry of Health, Labour and Welfare.[cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.mhlw.go.jp/english/policy/health-medical/pharmaceuticals/180822-01.html
- PRIME: Priority Medicines [Internet]. European Medicines Agency. [cited 2021 Dec 28]. Available from 2021 Dec 28: http://www.ema.europa.eu/ema/index.jsp%3Fcurl%3Dpages/regulation/general/general_content_000660.jsp%26mid%3DWC0b01ac058096f643.
- Johnston JL, Dhruva SS, Ross JS, et al. Early experience with the FDA’s breakthrough devices program. Nat Biotechnol. 2020 Aug;38(8):933–938.
- Act On Nurturing Medical Devices Industry And Supporting Innovative Medical Devices [Internet]. Korea Legislation Research Institute [cited 2021 Dec 28]. Available from 2021 Dec 28: https://elaw.klri.re.kr/kor_service/lawView.do?hseq=56244&lang=ENG .
- Enforcement Decree Of The Act On Nurturing Medical Devices Industry And Supporting Innovative Medical Devices [Internet]. Korea Legislation Research Institute [cited 2021 Dec 28]. Available from 2021 Dec 28:https://elaw.klri.re.kr/kor_service/lawView.do?hseq=59913&lang=ENG
- Kondo H, Hata T, Ito K, et al. The current status of sakigake designation in Japan, prime in the european union, and breakthrough therapy designation in the United States. Ther Innov Regul Sci. 2017 Jan;51(1):51–54. Epub 2016 Sep 27.
- Yang Y, Deng J. Research and thinking of international coordination documents for medical device labeling. Zhongguo Yi Liao Qi Xie Za Zhi. 2021 Feb 8;45(1):81–84. Chinese.
- Sun J, Wu K, Liu B, et al. IMDRF essential principles of safety and performance of medical devices and IVD medical devices introduction and consideration. Zhongguo Yi Liao Qi Xie Za Zhi. 2021 Feb 8;45(1):62–66. Chinese.
- Chen YJ, Chiou CM, Huang YW, et al. A comparative study of medical device regulations:: US, Europe, Canada, and Taiwan. Ther Innov Regul Sci. 2018 Jan;52(1):62–69. Epub 2017 Jul 7.
- Imagawa K, Mizukami Y, Miyazaki S. Regulatory convergence of medical devices: a case study using ISO and IEC standards. Expert Rev Med Devices. 2018 Jul;15(7):497–504. Epub 2018 Jul 11.
- Moshi MR, Parsons J, Tooher R, et al. Evaluation of mobile health applications: is regulatory policy up to the challenge? Int J Technol Assess Health Care. 2019;35(4):351–360.
- Parums DV. Editorial: global initiatives support the use and regulation of digital health technology during the covid-19 pandemic. Med Sci Monit. 2021 Oct 18;27:e935123
- International Medical Device Regulators Forum [Internet]. [cited 2021. 12. 28]. Available from: https://www.imdrf.org
- MacCormick A, Jenkins P, Roobottom C. Medical app minefield: radiologists use of medical apps for education and reporting and do they require regulation? Clin Radiol. 2021 Oct;76(10):774–778. Epub 2021 Jun 8.
- Keutzer L, Simonsson US. Medical device apps: an introduction to regulatory affairs for developers. JMIR Mhealth Uhealth. 2020 Jun 26;8(6):e17567.
- Moshi MR, Parsons J, Tooher R, et al. Evaluation of mobile health applications: is regulatory policy up to the challenge? Int J Technol Assess Health Care. 2019. 35(4):351–360. Epub 2019 Jul 16.
- U.S.C. 360e–3 Breakthrough devices [Internet] govinfo. [cited 2021 Dec 28]. Available from 2021 Dec 28 https://www.govinfo.gov/app/details/USCODE-2016-title21/USCODE-2016-title21-chap9-subchapV-partA-sec360e-3
- Requests for Feedback and Meetings for Medical Device Submissions: The Q-submission program. US Food and Drug Administration; 2019 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/media/114034/download
- Factors to consider when making benefit-risk determinations in medical device premarket approval and De Novo classifications (benefit risk final guidance). US Food and Drug Administration; 2019 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/media/99769/download
- Breakthrough Devices Program Final Guidance. US Food and Drug Administration; 2018 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/media/108135/download
- Guideline on Priority Review of Innovative Medical Devices. Korea ministry of food and drug safety; 2021 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20211026082243424.pdf&rs=/docviewer/result/data0011/14928/1/202201
- Guideline on innovative medical device screening guidelines.Korea ministry of food and drug safety; 2020 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20200908015340721.pdf&rs=/docviewer/result/data0011/14597/1/202201
- Guideline on the procedure, method, and standards for designation of innovative medical devices. Korea Ministry of Food and Drug Safety; 2020 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20200625014003621.pdf&rs=/docviewer/result/data0011/14567/1/202201
- Reflections on a record year for novel device innovation despite COVID-19 challenges [internet]. US Food and Drug Administration. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/news-events/fda-voices/reflections-record-year-novel-device-innovation-despite-covid-19-challenges
- US Breakthrough Devices [Internet]. Medtech Insight. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://medtech.pharmaintelligence.informa.com/datasets/us-breakthrough-devices .
- Section 513(f)(2)(De Novo) database [internet]. US food and drug administration. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/denovo.cfm .
- FDA Authorizes Software that Can Help Identify Prostate Cancer [Internet]. US Food and Drug Administration. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/news-events/press-announcements/fda-authorizes-software-can-help-identify-prostate-cancer
- 510(k) Premarket Notification Database [Internet]. US Food and Drug Administration. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K212616
- Koios Medical Smart Ultrasound AI Software Gets FDA Nod [Internet]. AppliedRadiology. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.appliedradiology.com/communities/Breast-Imaging/koios-medical-smart-ultrasound-ai-software-gets-fda
- Announcement of designation of innovative medical devices [internet]. Korea ministry of food and drug safety. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.mfds.go.kr/brd/m_76/list.do?multi_itm_seq=0&board_id=ntc0004&seq=&data_stts_gubun=C9999&srchTp=0&srchWord=%ED%98%81%EC%8B%A0%EC%9D%98%EB%A3%8C%EA%B8%B0%EA%B8%B0+%EC%A7%80%EC%A0%95+%EA%B3%B5%EA%B3%A0 .
- Press reference [Internet]. Korea ministry of food and drug safety. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20211202090026708.hwp&rs=/docviewer/result/ntc0021/45976/1/202201
- Medical Device DataBase [Internet]. Korea ministry of food and drug safety. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://udiportal.mfds.go.kr/search/data/P02_01 .
- Son J, Shin JY, Kim HD, et al. Development and validation of deep learning models for screening multiple abnormal findings in retinal fundus images. Ophthalmology. 2020 Jan;127(1):85–94. Epub 2019 May 31.
- Vunomed Funders AI, a fundus reading solution, has obtained a third-grade license from the ministry of food and drug safety [internet]. TECHWORLD. [cited 2021 Dec 28]. Available from 2021 Dec 28: http://www.epnc.co.kr/news/articleView.html?idxno=95190
- Shin DH, Heo H, Song S, et al. Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2021 Apr[Epub 2021 Mar 17];85:84–90
- World’s first MRI-based Parkinson’s disease diagnostic AI solution [Internet]. Heuron. cited 2021 Dec 28]. Available from 2021 Dec 28: https://iheuron.com/cns/HeuronParkinson
- Huran approves the approval of “mPDia” ministry of food and drug safety for grade 3 medical devices [internet]. Medical News. [cited 2021 Dec 28]. Available from 2021 Dec 28: http://www.bosa.co.kr/news/articleView.html?idxno=2147931
- Kim EY, Kim YJ, Choi WJ, et al. Performance of a deep-learning algorithm for referable thoracic abnormalities on chest radiographs: a multicenter study of a health screening cohort. PLoS One. 2021 Feb 19;16(2):e0246472.
- Lunit Insight CXR is the first AI to diagnose lung diseases to be designated as an innovative medical device by the ministry of food and drug safety. about 1.8 million copies of cumulative commercial analysis in Korea [Internet]. Lunit. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://lunit-kr.prezly.com/lunis-insaiteu-cxr-pye-jilhwan-jindan-bojo-ai-choecholo-sig-yagcheo-hyeogsin-uilyogigi-jijeonggugnae-nujeog-sang-yong-bunseog-yag-180man-jang
- News Room [Internet]. CoreLine. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.corelinesoft.com/newsroom-kor/
- Coreline Soft and Brain Image Detection and Diagnosis Assistance SW Obtained Grade 3 Medical Device [Internet]. RAPPORTIAN. [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.rapportian.com/news/articleView.html?idxno=142296
- Lee SE, Son NH, Kim MH, et al. Mammographic density assessment by artificial intelligence-based computer-assisted diagnosis: a comparison with automated volumetric assessment. J Digit Imaging. 2022 Jan 11; 10.1007/s10278-021-00555-x. Epub ahead of print.
- Lunit, “Lunit insight MMG” approved by the US FDA [internet]. MedigateNews. [cited 2021 Dec 28]. Available from 2021 Dec 28: http://medigatenews.com/news/1823984218
- Machine learning-enabled medical devices—a subset of artificial intelligence-enabled medical devices: key terms and definitions(proposed document). International Medical Device Regulators Forum; 2021 [cited 2021 Dec 28]. Available from: https://www.imdrf.org/sites/default/files/2021-10/Machine%20Learning-enabled%20Medical%20Devices%20-%20A%20subset%20of%20Artificial%20Intelligence-enabled%20Medical%20Devices%20-%20Key%20Terms%20and%20Definitions.pdf .
- Artificial Intelligence and Machine Learning (AI/ML) Software as a medical device action plan. The FDA; 2021 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/media/145022/download
- Proposed regulatory framework for modifications to artificial intelligence/machine learning-based software as a medical device. The FDA; 2019 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/files/medical%20devices/published/US-FDA-artificial-intelligence-and-machine-learning-discussion-paper.pdf .
- Guideline on Review and Approval of Artificial Intelligence(AI) and big data-based medical devices. Korea Ministry of Food and Drug Safety; 2020 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.mfds.go.kr/eng/brd/m_40/view.do?seq=72623&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1
- Clinical effectiveness evaluation of artificial intelligence (AI)-based medical devices. Korea Ministry of Food and Drug Safety; 2017 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.mfds.go.kr/brd/m_1060/view.do?seq=13613&srchFr=&srchTo=&srchWord=&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&Data_stts_gubun=C1004&page=1 .
- Goldenberg SL, Nir G, Salcudean SE. A new era: artificial intelligence and machine learning in prostate cancer. Nat Rev Urol. 2019 Jul;16(7):391–403.
- Milne-Ives M, de Cock C, Lim E, et al. The effectiveness of artificial intelligence conversational agents in health care: systematic review. J Med Internet Res. 2020 Oct 22;22(10):e20346.
- Krittanawong C, Rogers AJ, Johnson KW, et al. Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management. Nat Rev Cardiol. 2021 Feb;18(2):75–91. Epub 2020 Oct 9.
- Wiljer D, Salhia M, Dolatabadi E, et al. Accelerating the appropriate adoption of artificial intelligence in health care: protocol for a multistepped approach. JMIR Res Protoc. 2021 Oct 6;10(10):e30940.
- Basatneh R, Najafi B, Armstrong DG. Health sensors, smart home devices, and the internet of medical things: an opportunity for dramatic improvement in care for the lower extremity complications of diabetes. J Diabetes Sci Technol. 2018 May;12(3):577–586. Epub 2018 Apr 11.
- Poncette AS, Spies C, Mosch L, et al. Clinical requirements of future patient monitoring in the intensive care unit: qualitative study. JMIR Med Inform. 2019 Apr 30;7(2):e13064.
- Herrero-Martinez E, Hussain N, Roux NL, et al. Dynamic regulatory assessment: evolving the european regulatory framework for the benefit of patients and public health-an EFPIA view. Clin Ther. 2021 Nov 27;S0149-2918(21): 456–2. 10.1016/j.clinthera.2021.11.001. Epub ahead of print.
- Software as a medical device (SaMD): key definitions. International Medical Device Regulators Forum; 2013 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-131209-samd-key-definitions-140901.pdf
- Software as a medical device: possible framework for risk categorization and corresponding considerations. International Medical Device Regulators Forum; 2014 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf
- Software as a medical device (SaMD): clinical evaluation. International Medical Device Regulators Forum; 2017 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-170921-samd-n41-clinical-evaluation_1.pdf
- Software as a medical device (SaMD): application of quality management system. International Medical Device Regulators Forum; 2015 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-151002-samd-qms.pdf
- Bideault G, Scaccia A, Zahel T, et al. Verification and validation of computational models used in biopharmaceutical manufacturing: potential application of the asme verification and validation 40 standard and FDA Proposed AI/ML model life cycle management framework. J Pharm Sci. 2021 Apr;110:1540–1544. Epub 2021 Jan 23.
- Innovative medical device technology and standard development status report. National Institute of Medical Device Safety Information; 2021 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.nids.or.kr/board/view.jsp?page=fi&flag=view&data_seq=9032&i_current_page=1&mnu=8&tabno=0&category=2
- Strategy of SAKIGAKE [Internet]. Japan ministry of health, labour and welfare. [cited 2022 Jan 02]. Available from 2022 Jan 02: https://www.mhlw.go.jp/english/policy/health-medical/pharmaceuticals/140729-01.html
- Notice related to the evaluation work [internet]. China national medical products administration. [cited 2022 Jan 02]. Available from 2022 Jan 02: https://www.cmde.org.cn/CL0050/index_1.html
- Digital Health Innovation Action Plan. The FDA; 2017 [cited 2022 Jan 02]. Available from 2022 Jan 02: https://www.fda.gov/media/106331/download
- Digital Health Center of Excellence [Internet]. US Food and Drug Administration. [cited 2022 Jan 02]. Available from 2022 Jan 02: https://www.fda.gov/medical-devices/digital-health-center-excellence
- Support for rapid commercialization of digital therapy devices [internet]. Korea ministry of food and drug safety. [cited 2022 Jan 02]. Available from 2022 Jan 02: https://www.mfds.go.kr/brd/m_99/view.do?seq=45990
- Digital Health Regulation In Asia-Pacific: China and Korea. APACMED; 2021 [cited 2022 Jan 02]. Available from: https://apacmed.org/content/uploads/2021/10/DHC-regulatory-paper_China-Korea.pdf
- Kantor A, Haga SB. The potential benefit of expedited development and approval programs in precision medicine. J Pers Med. 2021 Jan 14;11(1):45.
- Liberti L, Bujar M, Breckenridge A, et al. FDA facilitated regulatory pathways: visualizing their characteristics, development, and authorization timelines. Front Pharmacol. 2017 Apr 3;8:161
- Guideline on advanced medical device phase-by-step approval review. Korea Ministry of Food and Drug Safety; 2020 [cited 2022 Jan 02]. Available from 2022 Jan 02: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20200601041959107.pdf&rs=/docviewer/result/data0011/14538/1/202201
- Guideline on designation of permission assistants for newly developed medical devices, etc. and operating(revised). Korea Ministry of Food and Drug Safety; 2021 [cited 2022 Jan 02]. Available from 2022 Jan 02: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20210802022748054.pdf&rs=/docviewer/result/data0010/14857/1/202201
- Shiroiwa T. Cost-effectiveness evaluation for pricing medicines and devices: a new value-based price adjustment system in Japan. Int J Technol Assess Health Care. 2020 Jun;36(3):270–276. Epub 2020 May 18.
- Gerke S, Stern AD, Minssen T Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries. NPJ Digit Med. 2020 Jul 10;3:94.
- Smith MY, van Til J, DiSantostefano RL, et al. Quantitative benefit-risk assessment: state of the practice within industry. Ther Innov Regul Sci. 2021 Mar;55(2):415–425. Epub 2020 Oct 27.
- Benefit-risk factors to consider when determining substantial equivalence in premarket notifications (510(k)) with different technological characteristics. US Food and Drug Administration; 2018 [cited 2021 Dec 28]. Available from 2021 Dec 28: https://www.fda.gov/media/89019/download
- Fu B, Li X, Scott J, et al. A new framework to address challenges in quantitative benefit-risk assessment for medical products. Contemp Clin Trials. 2020 Aug;95:106073 Epub 2020 Jul 3.
- Angehrn Z, Haldna L, Zandvliet AS, et al. Artificial Intelligence and machine learning applied at the point of care. Front Pharmacol. 2020 Jun 18;11:759.
- Arora A. Conceptualising artificial Intelligence as a digital healthcare innovation: an introductory review. Med Devices (Auckl). 2020 Aug 20;13:223–230
- O’Neill T, Miksad R, Miller D, et al. ISPOR, the FDA, and the evolving regulatory science of medical device products. Value Health. 2019 Jul;22(7):754–761. Epub 2019 Jun 8.
- Lee AY, Yanagihara RT, Lee CS, et al. Multicenter, head-to-head, real-world validation study of seven automated artificial intelligence diabetic retinopathy screening systems. Diabetes Care. 2021 May;44(5):1168–1175. Epub 2021 Jan 5.
- Dhruva SS, Shah ND, Ross JS. Mandatory registration and results reporting of real-world evidence studies of FDA-regulated medical products. Mayo Clin Proc. 2020 Dec;95(12):2609–2611. Epub 2020 Oct 21.
- Chen M, Decary M. Artificial intelligence in healthcare: an essential guide for health leaders. Healthc Manage Forum. 2020 Jan;33(1):10–18. Epub 2019 Sep 24.
- Zhou Q, Qi S, Xiao B, et al. [Artificial intelligence empowers laboratory medicine in Industry 4.0]. Nan Fang Yi Ke Da Xue Xue Bao. 2020 Feb 29;40(2):287–296. Chinese.
- Kim H. AI, big data, and robots for the evolution of biotechnology. Genomics Inform. 2019 Dec;17(4):e44. Epub 2019 Nov 13.
- Mazurowski MA. Artificial intelligence in radiology: some ethical considerations for radiologists and algorithm developers. Acad Radiol. 2020 Jan;27(1):127–129.
- Abd-Alrazaq A, Alajlani M, Alhuwail D, et al. Artificial intelligence in the fight against COVID-19: scoping review. J Med Internet Res. 2020 Dec 15;22(12):e20756.
- Kapoor A, Guha S, Kanti Das M, et al. Digital healthcare: the only solution for better healthcare during COVID-19 pandemic? Indian Heart J. 2020 Mar-Apr;72(2):61–64. Epub 2020 Apr 11.
- Mahmood S, Hasan K, Colder Carras M, et al. Global preparedness against Covid-19: we must leverage the power of digital health. JMIR Public Health Surveill. 2020 Apr 16;6(2):e18980.
- Wang Q, Su M, Zhang M, et al. Integrating digital technologies and public health to fight covid-19 pandemic: key technologies, applications, challenges and outlook of digital healthcare. Int J Environ Res Public Health. 2021 jun 4;18(11):6053.
- Nordyke RJ, Appelbaum K, Berman MA. Estimating the impact of novel digital therapeutics in type 2 diabetes and hypertension health economic analysis. J Med Internet Res 2019 Oct 9 21(10):e15814.
- Sverdlov O, van Dam J, Hannesdottir K, et al. Digital therapeutics: an integral component of digital innovation in drug development. Clin Pharmacol Ther. 2018 Jul;104(1):72–80. Epub 2018 Feb 23.
- Aapro M, Bossi P, Dasari A, et al. Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Support Care Cancer. 2020 Oct;28(10):4589–4612. Epub 2020 Jun 12.
- Khirasaria R, Singh V, Batta A. Exploring digital therapeutics: the next paradigm of modern health-care industry. Perspect Clin Res. 2020 Apr-Jun;11(2):54–58. Epub 2020 May 6.
- Dorsey ER, Okun MS, Bloem BR. Care, convenience, comfort, confidentiality, and contagion: the 5 c’s that will shape the future of telemedicine. J Parkinsons Dis. 2020;10(3):893–897.
- Command Center Solutions for Real Time Healthcare [Internet]. GE Healthcare. [cited 2022 Feb 24]. Available from 2022 Feb 24: https://www.gehccommandcenter.com
- Pimenta C, Bettiol V, Alencar-Silva T, et al. Advanced therapies and regulatory framework in different areas of the globe: past, present, and future. Clin Ther. 2021 May;43(5):e103–e138. Epub 2021 Apr 21.
- Wang Y, Guan A, Wickramasekara S, et al. Analytical chemistry in the regulatory science of medical devices. Annu Rev Anal Chem (Palo Alto Calif). 2018 Jun 12;11(1):307–327. Epub 2018 Mar 26.
- FY 2020 OCP Performance Report. US Food and Drug Administration; 2021 [cited 2022 Jan 02]. Available from 2022 Jan 02: https://www.fda.gov/media/154949/download
- 2020 Medical Product Approval Reports. Korea ministry of food and drug safety. 2021 cited 2022 Jan 02. Available from 2022 Jan 02: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20210802024257665.pdf&rs=/docviewer/result/eng0012/70935/1/202201